Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, open-label, fasting, single dose, crossover study to investigate
the pharmacokinetic profiles and safety of high-dose CKD-385 in healthy volunteers under
fasting conditions.